China Traditional Chinese Medicine Holdings Co. Limited (0570.HK)
HKD 2.31
(-0.86%)
HKD 2.31
(-0.86%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 2.19 Billion CNY | 314.19% |
| 2022 | 528.93 Million CNY | -81.72% |
| 2021 | 2.89 Billion CNY | 13.81% |
| 2020 | 2.54 Billion CNY | 869.35% |
| 2019 | 262.22 Million CNY | -88.21% |
| 2018 | 2.22 Billion CNY | -50.73% |
| 2017 | 4.51 Billion CNY | 55.23% |
| 2016 | 2.9 Billion CNY | 242.06% |
| 2015 | 850.3 Million CNY | 26.8% |
| 2014 | 670.56 Million CNY | 0.34% |
| 2013 | 668.27 Million CNY | 4778.94% |
| 2012 | -14.28 Million CNY | 0.0% |
| 2011 | - CNY | 0.0% |
| 2010 | - CNY | 0.0% |
| 2009 | - CNY | 0.0% |
| 2008 | - CNY | 0.0% |
| 2007 | - CNY | 0.0% |
| 2006 | - CNY | -100.0% |
| 2005 | 413.23 Million CNY | 5.5% |
| 2004 | 391.68 Million CNY | 8.17% |
| 2003 | 362.09 Million CNY | 1.97% |
| 2002 | 355.09 Million CNY | -21.0% |
| 2001 | 449.49 Million CNY | -18.33% |
| 2000 | 550.39 Million CNY | -16.83% |
| 1999 | 661.74 Million CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 1.91 Billion CNY | -9.33% |
| 2024 Q2 | 1.91 Billion CNY | 0.0% |
| 2023 Q3 | 2.19 Billion CNY | -1.1% |
| 2023 Q4 | 2.19 Billion CNY | 0.0% |
| 2023 FY | 2.19 Billion CNY | 314.19% |
| 2023 Q2 | 2.21 Billion CNY | 0.0% |
| 2023 Q1 | 2.21 Billion CNY | 318.79% |
| 2022 Q1 | 619.77 Million CNY | -78.58% |
| 2022 Q3 | 528.93 Million CNY | -14.66% |
| 2022 Q4 | 528.93 Million CNY | 0.0% |
| 2022 FY | 528.93 Million CNY | -81.72% |
| 2022 Q2 | 619.77 Million CNY | 0.0% |
| 2021 Q4 | 2.89 Billion CNY | 0.0% |
| 2021 Q1 | 2.87 Billion CNY | 13.19% |
| 2021 Q3 | 2.89 Billion CNY | 0.55% |
| 2021 Q2 | 2.87 Billion CNY | 0.0% |
| 2021 FY | 2.89 Billion CNY | 13.81% |
| 2020 Q2 | 2.49 Billion CNY | 0.0% |
| 2020 Q4 | 2.54 Billion CNY | 0.0% |
| 2020 FY | 2.54 Billion CNY | 869.35% |
| 2020 Q1 | 2.49 Billion CNY | 850.11% |
| 2020 Q3 | 2.54 Billion CNY | 2.03% |
| 2019 Q2 | 286.3 Million CNY | 0.0% |
| 2019 Q4 | 262.22 Million CNY | 0.0% |
| 2019 Q3 | 262.22 Million CNY | -8.41% |
| 2019 Q1 | 286.3 Million CNY | -87.13% |
| 2019 FY | 262.22 Million CNY | -88.21% |
| 2018 Q4 | 2.22 Billion CNY | 0.0% |
| 2018 Q1 | 4.54 Billion CNY | 0.66% |
| 2018 FY | 2.22 Billion CNY | -50.73% |
| 2018 Q2 | 4.54 Billion CNY | 0.0% |
| 2018 Q3 | 2.22 Billion CNY | -51.05% |
| 2017 Q4 | 4.51 Billion CNY | 0.0% |
| 2017 Q1 | 4.88 Billion CNY | 67.92% |
| 2017 Q3 | 4.51 Billion CNY | -7.55% |
| 2017 FY | 4.51 Billion CNY | 55.23% |
| 2017 Q2 | 4.88 Billion CNY | 0.0% |
| 2016 Q3 | 2.9 Billion CNY | 3630.52% |
| 2016 Q2 | -82.38 Million CNY | 0.0% |
| 2016 Q1 | - CNY | -100.0% |
| 2016 Q4 | 2.9 Billion CNY | 0.0% |
| 2016 FY | 2.9 Billion CNY | 242.06% |
| 2015 Q2 | 680.42 Million CNY | 0.0% |
| 2015 Q4 | 850.3 Million CNY | 0.0% |
| 2015 FY | 850.3 Million CNY | 26.8% |
| 2015 Q3 | 850.3 Million CNY | 24.97% |
| 2015 Q1 | 680.42 Million CNY | 1.47% |
| 2014 Q2 | 674.68 Million CNY | 0.0% |
| 2014 FY | 670.56 Million CNY | 0.34% |
| 2014 Q4 | 670.56 Million CNY | 0.0% |
| 2014 Q1 | 674.68 Million CNY | 0.96% |
| 2014 Q3 | 670.56 Million CNY | -0.61% |
| 2013 Q3 | 668.27 Million CNY | 5102.58% |
| 2013 FY | 668.27 Million CNY | 4778.94% |
| 2013 Q4 | 668.27 Million CNY | 0.0% |
| 2013 Q2 | -13.35 Million CNY | 0.0% |
| 2013 Q1 | - CNY | 100.0% |
| 2012 Q3 | - CNY | 0.0% |
| 2012 FY | -14.28 Million CNY | 0.0% |
| 2012 Q2 | - CNY | 0.0% |
| 2012 Q4 | -14.28 Million CNY | 0.0% |
| 2011 Q4 | - CNY | 0.0% |
| 2011 Q2 | - CNY | 0.0% |
| 2011 FY | - CNY | 0.0% |
| 2010 Q4 | - CNY | 0.0% |
| 2010 FY | - CNY | 0.0% |
| 2010 Q2 | - CNY | 0.0% |
| 2009 Q4 | - CNY | 0.0% |
| 2009 FY | - CNY | 0.0% |
| 2009 Q2 | - CNY | 0.0% |
| 2008 FY | - CNY | 0.0% |
| 2008 Q4 | - CNY | 0.0% |
| 2007 FY | - CNY | 0.0% |
| 2006 FY | - CNY | -100.0% |
| 2005 FY | 413.23 Million CNY | 5.5% |
| 2004 FY | 391.68 Million CNY | 8.17% |
| 2003 FY | 362.09 Million CNY | 1.97% |
| 2002 FY | 355.09 Million CNY | -21.0% |
| 2001 FY | 449.49 Million CNY | -18.33% |
| 2000 FY | 550.39 Million CNY | -16.83% |
| 1999 FY | 661.74 Million CNY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 2.07 Million HKD | -105582.347% |
| Grand Pharmaceutical Group Limited | 990.02 Million HKD | -121.286% |
| Extrawell Pharmaceutical Holdings Limited | 117.12 Million HKD | -1770.491% |
| Wai Yuen Tong Medicine Holdings Limited | 276.2 Million HKD | -693.191% |
| Qianhai Health Holdings Limited | - HKD | -Infinity% |
| Lee's Pharmaceutical Holdings Limited | 70.63 Million HKD | -3001.526% |
| Essex Bio-Technology Limited | 36.05 Million HKD | -5975.965% |
| Tongfang Kontafarma Holdings Limited | 12.8 Million HKD | -17014.241% |
| PuraPharm Corporation Limited | 81.09 Million HKD | -2601.582% |
| SSY Group Limited | 1.94 Billion HKD | -12.489% |
| JBM (Healthcare) Limited | 43.8 Million HKD | -4901.813% |
| Jacobson Pharma Corporation Limited | 592.2 Million HKD | -269.942% |
| China Resources Pharmaceutical Group Limited | 16.61 Billion HKD | 86.816% |